Last reviewed · How we verify

NCT05318014

Low-protein Formula Supplements in Chronic Kidney Disease

Completed NA Last updated 8 April 2022
What this trial tests

NA trial testing Intervention group in Chronic Kidney Disease in 95 participants. Completed in 31 December 2021.

Timeline
25 September 2019
Primary endpoint
31 October 2020
31 December 2021

Quick facts

Lead sponsorTaichung Veterans General Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment95
Start date25 September 2019
Primary completion31 October 2020
Estimated completion31 December 2021
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Taichung Veterans General Hospital

Who can join

65 and older, any sex, with Chronic Kidney Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective randomized contorl study.Comparing clinical outcome between chronic kidney disease who were prescribed 6% low-protein nutrition supplement along with dietatian regular nutrition education and those without oral nutrition supplement.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Effects of a low-protein nutritional formula with dietary counseling in older adults with chronic kidney disease stages 3-5: a randomized controlled trial.
    Yang WC, Hsieh HM, Chen JP, Liu LC, et al · · 2023 · cited 2× · PMID 38097963 · DOI 10.1186/s12882-023-03423-8

Verify or expand the search:

Other trials of Intervention group

Trials testing the same drug.

Other recruiting trials for Chronic Kidney Disease

Currently open trials in the same condition.

Other Taichung Veterans General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05318014.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing